Skip to main content
SpringerLink
Log in

Pharmacological properties and mechanisms of action of new antidepressants (review)

  • Molecular-Biological Problems in the Creation of Therapeutic Agents and Studies of their Mechanisms of Action
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literature cited

  1. G. Ya. Avrutskii and O. P. Vertogradova, New Therapeutic Agents, Ékspress-inform., No. 1, 9–20 (1973).

    Google Scholar 

  2. N. I. Andreeva, R. G. Glushkov, and M. D. Mashkovskii, Khim.-farm. Zh., No. 4, 111–114 (1979).

    Google Scholar 

  3. A Handbook of the Scientific Studies of the Science Research Institute of Pharmacology [in Russian], A. V. Vel'dman (ed.), Moscow (1990).

  4. I. P. Lapin, Antidepressants and Nootropic Agents [in Russian], Leningrad (1982), pp. 88–101.

  5. M. D. Mashkovskii, A. N. Grinev, and N. I. Andreeva, Khim.-farm. Zh., No. 3, 60–63 (1974).

    Google Scholar 

  6. G. P. Panteleeva, B. S. Belyaev, K. E. Borisova, et al., Antidepressants and Nootropic Agents [in Russian], Leningrad (1982), pp. 42–48.

  7. V. N. Sinyukhin, The Metabolism of the New Antidepressant Azafen and its Effects on Noradrenaline Metabolism [in Russian], Author's abstract of dissertation for Doctorate in Medical Sciences, Moscow (1974).

  8. V. I. Fedortsov and A. N. Zavarzina, New Therapeutic Agents. Éksp.-inform., No. 8, 18–23 (1982).

    Google Scholar 

  9. M. A. Blackshear, L. R. Steranka, and E. Sanders-Buch, Eur. J. Pharmacol.,76, 325–328 (1981).

    Google Scholar 

  10. R. N. Brogden, et al., Drugs,18, 1–24 (1979).

    Google Scholar 

  11. R. N. Brogden, et al., Drugs,21, 401–429 (1981).

    Google Scholar 

  12. E. A. Burch, Jr. and J. H. Downs, J. Clin. Psychopharmacol.,7, 55–56 (1987).

    Google Scholar 

  13. G. D. Burrows, et al., (eds.), Antidepressant Drugs in Psychiatry, Amsterdam-New York-Oxford (1983), Vol. 1.

  14. J. Castaner and S. S. Chatterjee, Drugs Future,1, 551–554 (1976).

    Google Scholar 

  15. L. A. Chiodo and S. M. Antelman, Eur. J. Pharmacol.,66, 255–256 (1980).

    Google Scholar 

  16. V. Claasen, et al., Br. J. Pharmacol.,60, 505–516 (1977).

    Google Scholar 

  17. A. Coppen, et al., Psychopharmacology,63, 199–202 (1979).

    Google Scholar 

  18. R. A. Dominguez, et al., J. Clin, Psychiatr.,46, 84–87 (1985).

    Google Scholar 

  19. P. T. Donlon, H. Biertuemphez, and M. Willenbring, J. Clin. Psychiatr.,42, 11–15 (1981).

    Google Scholar 

  20. R. S. Ehsanuellah, et al., Psychopharmacology,52, 73–77 (1977).

    Google Scholar 

  21. Ch. J. Fowler, Drugs Future,7, 501–517 (1982).

    Google Scholar 

  22. R. W. Fuller, H. D. Snoddy, and K. W. Perry, Neuropharmacology,18, 767–770 (1979).

    Google Scholar 

  23. K. Fuxe, S. O. Orgen, L. G. Agnati, et al., Neuropharmacology,22, 389–400 (1983).

    Google Scholar 

  24. K. Fuxe, et al., Typical and Atypical Antidepressants, New York (1982), pp. 91–107.

  25. M. Grau, Drugs Future,8, 124–126 (1983).

    Google Scholar 

  26. H. Hall and S. O. Orgen, Eur. J. Pharmacol.,70, 393–407 (1981).

    Google Scholar 

  27. A. Yanowsky, et al., Science,218, 900–901 (1982).

    Google Scholar 

  28. J. F. Ancher, Med. Actual/Drugs Today,20, 417–422 (1984).

    Google Scholar 

  29. S. Lipper, et al., Psychopharmacology,62, 123–128 (1979).

    Google Scholar 

  30. A. Moretti, et al., Biochem. Pharmacol.,30, 2728–2731 (1981).

    Google Scholar 

  31. S. O. Orgel, S. Ross, H. Hall, and T. Archer, Antidepressants, G. D. Burrows, et al. (eds.), Amsterdam-New York-Oxford (1983), pp. 13–34.

  32. M. Peet and H. Behagel, B. J. Clin. Pharmacol.,5, Suppl. 1, 5–9 (1978).

    Google Scholar 

  33. R. M. Pinder, et al., Drugs,13, 321–352 (1977).

    Google Scholar 

  34. R. M. Pinder, et al., Drugs,13, 401–421 (1977).

    Google Scholar 

  35. C. P. Robinson, Drugs Today,24, 7–13 (1988).

    Google Scholar 

  36. M. V. Rudorfer and W. Z. Potter, Drugs,37, 713–738 (1989).

    Google Scholar 

  37. A. F. Schatzeberg, et al., J. Clin. Psychopharmacol.,7, 44S-49S (1987).

    Google Scholar 

  38. W. C. Stern and N. Harto-Truax, Psychopharmacol. Bull.,16, 43–46 (1980).

    Google Scholar 

  39. M. F. Sugrue, Biochem. Pharmacol.,32, 1811–1817 (1983).

    Google Scholar 

  40. F. Sulser, J. Vetulani, and P. Mobley, Biochem. Pharmacol.,27, 257–261 (1978).

    Google Scholar 

  41. P. Waldmeier and W. Schilling, Drugs Future,10, 371–373 (1985).

    Google Scholar 

  42. K. A. Wesnes, et al., Brit. J. Clin. Pharmacol.,27, 647P-648P (1989).

    Google Scholar 

  43. P. Willner, Psychopharmacology,85, 387–404 (1985).

    Google Scholar 

  44. M. B. H. Youdim, M. Da Prada, and R. Emrein (eds.), J. Neural. Transmission. Supplement 26 (1988).

Download references

Author information

Authors and Affiliations

  1. TsKhLS. S. Ordzhonikidze All-Union Scientific-Pharmaceutical Institute, Moscow

    N. I. Andreeva

Authors
  1. N. I. Andreeva
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 27, No. 7, pp. 4–11, July, 1993.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andreeva, N.I. Pharmacological properties and mechanisms of action of new antidepressants (review). Pharm Chem J 27, 453–463 (1993). https://doi.org/10.1007/BF00780195

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00780195

Keywords

Search

Navigation